Ice cream could lick chemo side-effects

Clinical trials are under way for New Zealand-developed medical ice cream.
An innovative new medical ice cream developed by Fonterra and the University of Auckland has shown early promise for combating some of the unpleasant side-effects of chemotherapy.
The ice cream, known as ReCharge, has started Phase 2 clinical trials in New Zealand to assess its effectiveness against chemotherapy induced diarrhoea and anaemia.
But the "dessert with a difference" could also reduce weight loss and damage to the immune system during chemotherapy.
Oncology centres at Whangarei, Auckland, Waikato, Palmerston North, Wellington, Christchurch, Dunedin and Invercargill are taking part in the trial. (Taranaki Daily News)  Click Title to view more.